101. N-Acyl and N-sulfonyloxazolidine-2,4-diones are pseudo-irreversible inhibitors of serine proteases
- Author
-
Jim Iley, Henrique F. Correia, Rita C. Guedes, Ana Bela Santana, Teresa A.F. Cardote, Lídia Gonçalves, Rui Moreira, and Susana D. Lucas
- Subjects
Proteases ,Cathepsin G ,Serine Proteinase Inhibitors ,Human neutrophil ,Stereochemistry ,Swine ,Clinical Biochemistry ,Anti-Inflammatory Agents ,Pharmaceutical Science ,Inhibitory postsynaptic potential ,Biochemistry ,Serine ,Structure-Activity Relationship ,Drug Discovery ,Animals ,Humans ,Mode of action ,Molecular Biology ,Pancreatic elastase ,Oxazolidinones ,Cathepsin ,Pancreatic Elastase ,Chemistry ,Organic Chemistry ,Elastase ,Kinetics ,Molecular Medicine ,Leukocyte Elastase - Abstract
The synthesis, inhibitory activity and mode of action of oxazolidine-2,4-diones against porcine pancreatic elastase, here used as a model for human neutrophil elastase, are reported. The nature of N-substitution at the oxazolidine-2,4-dione scaffold has large effect on the inhibitory potency against elastase. N-Acyl and N-sulfonyloxazolidine-2,4-diones emerged as potent pseudo-irreversible inhibitors, displaying high second-order rate constants for PPE inactivation. The title compounds were also shown to be potent inhibitors of human neutrophil elastase (HNE) and proteinase-3, and weak inhibitors of human cathepsin G. The results herein presented show that the oxazolidine-2,4-diones represent a new promising class of serine protease inhibitors.
- Published
- 2011